Task: Answer the multiple-choice question.
Question: Which compound exhibits a 12.565% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] Nc1nc(NCC2CCCO2)nc(Nc2ccc(Cl)cc2)c1[N+](=O)[O-]
[b] Cl.NCCCC[C@H](NC(=O)C1CCNCC1)c1nnc([C@@H](N)Cc2ccc(O)cc2)o1
Answer: a. Nc1nc(NCC2CCCO2)nc(Nc2ccc(Cl)cc2)c1[N+](=O)[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1nc(NCC2CCCO2)nc(Nc2ccc(Cl)cc2)c1[N+](=O)[O-]
Nc1nc(NCC2CCCO2)nc(Nc2ccc(Cl)cc2)c1[N+](=O)[O-]
4-N-(4-chlorophenyl)-5-nitro-2-N-(oxolan-2-ylmethyl)pyrimidine-2,4,6-triamine